Genomic differences between retinoma and retinoblastoma

Acta Oncologica

Volumn 47, Issue 8, 2008, Pages 1483-1492

  Sampieri, Katia ^a   Mencarelli, Maria Antonietta ^a   Carmela Epistolato, Maria ^a   Toti, Paolo ^a   Lazzi, Stefano ^a   Bruttini, Mirella ^a   Francesco, Sonia De ^a   Longo, Ilaria ^a   Meloni, Ilaria ^a   Mari, Francesca ^a   Acquaviva, Antonio ^a   Hadjistilianou, Theodora ^a   Renieri, Alessandra ^a   Ariani, Francesca ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN MDMX; PROTEIN P22; TRANSCRIPTION FACTOR E2F3; UVOMORULIN;

ARTICLE; CANCER STAGING; CASE REPORT; CHILD; FEMALE; GENE; GENE NUMBER; GENETIC DIFFERENCE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINOBLASTOMA;

CADHERINS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; E2F3 TRANSCRIPTION FACTOR; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENE AMPLIFICATION; GENETIC MARKERS; GENOME, HUMAN; HUMANS; LASERS; MALE; MICRODISSECTION; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 54349098300     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802342382     Document Type: Article

References (38)

1. Knudson AG, Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
2. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 1999;59:1731s-5s.
3. Mairal A, Pinglier E, Gilbert E, Peter M, Validire P, Desjardins L, et al. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosome Cancer 2000;28:370-9.
4. Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2001;129:57-63.
5. Herzog S, Lohmann DR, Buiting K, Schuler A, Horsthemke B, Rehder H, et al. Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 2001;108:98-104.
6. Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, et al. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosome Cancer 2003;36:121-8.
7. van der Wal JE, Hermsen MA, Gille HJ, Schouten-Van Meeteren NY, Moll AC, Imhof SM, et al. Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. J Clin Pathol 2003;56:26-30.
8. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosome Cancer 2005;43:294-301.
9. Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosome Cancer 2007;46:118-29.
10. Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosome Cancer 2007;46:617-34.
11. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: Spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 1982;45:513-21.
12. Margo C, Hidayat A, Kopelman J, Zimmerman LE. Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol 1983;101:1519-31.
13. Sampieri K, Hadjistilianou T, Mari F, Speciale C, Mencarelli MA, Cetta F, et al. Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations. J Hum Genet 2006;51:209-16.
14. Balmer A, Munier F, Gailloud C. Retinoma. Case studies. Ophthalmic Paediatr Genet 1991;12:131-7.
15. Eagle RC, Jr, Shields JA, Donoso L, Milner RS. Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology 1989;96:1389-95.
16. Rubin ML. The tale of the warped cornea: A real-life melodrama. Arch Ophthalmol 1967;77:711-2.
17. Brockhurst RJ, Donaldson DD. Spontaneous resolution of probable retinoblastoma. Arch Ophthalmol 1970;84:388-9.
18. Morris WE, LaPiana FG. Spontaneous regression of bilateral multifocal retinoblastoma with preservation of normal visual acuity. Ann Ophthalmol 1974;6:1192-4.
19. Reese PD. The general ophthalmological examination for the non-ophthalmologist. J Ark Med Soc 1976;72:387-90.
20. Singh AD, Santos CM, Shields CL, Shields JA, Eagle RC, Jr. Observations on 17 patients with retinocytoma. Arch Ophthalmol 2000;118:199-205.
21. Dimaras H, Coburn B, Pajovic S, Gallie BL. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog 2006;45:333-43.
22. Rodriguez-Tebar A, Dechant G, Barde YA. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 1990;4:487-92.
23. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990;87:5454-8.
24. Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 1991;65:885-93.
25. Hallbook F, Ibanez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991;6:845-58.
26. Frade JM, Barde YA. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999;126:683-90.
27. Livak K. ABI Prism 7700 Sequence Detection System, 1997.
28. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006;444:61-6.
29. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, et al. Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008.
30. Zografos L. Tumeurs intraoculaires. París: Société Française d'Ophtalmologie, Masson, 2002.
31. Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M, et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002;13:215-25.
32. Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. Biochem Biophys Res Commun 2002;291:1138-45.
33. Ginsberg D. E2F3-a novel repressor of the ARF/p53 pathway. Dev Cell 2004;6:742-3.
34. Marine JC, Jochemsen AG. Mdmx and Mdm2: Brothers in arms? Cell Cycle 2004;3:900-4.
35. Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, et al. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2004;2:495-503.
36. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-4.
37. Markus MA, Reichmuth C, Atkinson MJ, Reich U, Hoffmann I, Balling R, et al. Cadherin- 11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro. J Pathol 1999;187:164-72.
38. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-52.